Cargando…

Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer

BACKGROUND: The peritoneal cavity contains many site-specific immune cells which constitute a unique immune microenvironment. However, it is unclear how the local immune signature is altered in patients with peritoneal metastases (PM). METHODS: Peritoneal lavage fluid or ascites were obtained from 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Kazuya, Kurashina, Kentaro, Yamaguchi, Hironori, Kanamaru, Rihito, Ohzawa, Hideyuki, Miyato, Hideyo, Saito, Shin, Hosoya, Yoshinori, Lefor, Alan Kawarai, Sata, Naohiro, Kitayama, Joji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478385/
https://www.ncbi.nlm.nih.gov/pubmed/36119051
http://dx.doi.org/10.3389/fimmu.2022.969468
_version_ 1784790559534088192
author Takahashi, Kazuya
Kurashina, Kentaro
Yamaguchi, Hironori
Kanamaru, Rihito
Ohzawa, Hideyuki
Miyato, Hideyo
Saito, Shin
Hosoya, Yoshinori
Lefor, Alan Kawarai
Sata, Naohiro
Kitayama, Joji
author_facet Takahashi, Kazuya
Kurashina, Kentaro
Yamaguchi, Hironori
Kanamaru, Rihito
Ohzawa, Hideyuki
Miyato, Hideyo
Saito, Shin
Hosoya, Yoshinori
Lefor, Alan Kawarai
Sata, Naohiro
Kitayama, Joji
author_sort Takahashi, Kazuya
collection PubMed
description BACKGROUND: The peritoneal cavity contains many site-specific immune cells which constitute a unique immune microenvironment. However, it is unclear how the local immune signature is altered in patients with peritoneal metastases (PM). METHODS: Peritoneal lavage fluid or ascites were obtained from 122 patients with various stages of gastric cancer (GC). Cells recovered from peritoneal fluids were immunostained with mAbs for lymphocyte-, macrophage- and tumor cell-specific antigens and the frequencies of leukocyte subsets and antigen expression levels were evaluated with multi-color flowcytometry. RESULTS: The proportions of CD8(+) T cells, CD3(+)CD56(+) NKT-like cells, and CD3(-)CD56(+) NK cells to CD45(+) leukocytes were significantly reduced in patients with PM compared to those without PM. In patients with PM, the rates of CD8 (+) T cells and NKT-like cells correlated inversely with the tumor leukocyte ratio (TLR), the relative frequency of CD326(+) tumor cells to CD45(+) leukocytes. In contrast, the proportion of CD19(+) B cells was significantly increased in patients with PM, and their proportion correlated positively with the TLR and peritoneal carcinomatosis index (PCI) score. In patients with PM, CD14(+) macrophages tended to be increased with enhanced expression of CD14, CD16 and a M2-macrophage marker, CD163. In particular, macrophages in patients with high TLR contained many granules with high side scatter and CD14 expression in their flow profile compared to those without PM. CONCLUSION: PM are accompanied by a drastic change in phenotypes of lymphocyte and macrophage in the peritoneal cavity, which might be involved in the development and progression of intraperitoneal tumor growth.
format Online
Article
Text
id pubmed-9478385
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94783852022-09-17 Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer Takahashi, Kazuya Kurashina, Kentaro Yamaguchi, Hironori Kanamaru, Rihito Ohzawa, Hideyuki Miyato, Hideyo Saito, Shin Hosoya, Yoshinori Lefor, Alan Kawarai Sata, Naohiro Kitayama, Joji Front Immunol Immunology BACKGROUND: The peritoneal cavity contains many site-specific immune cells which constitute a unique immune microenvironment. However, it is unclear how the local immune signature is altered in patients with peritoneal metastases (PM). METHODS: Peritoneal lavage fluid or ascites were obtained from 122 patients with various stages of gastric cancer (GC). Cells recovered from peritoneal fluids were immunostained with mAbs for lymphocyte-, macrophage- and tumor cell-specific antigens and the frequencies of leukocyte subsets and antigen expression levels were evaluated with multi-color flowcytometry. RESULTS: The proportions of CD8(+) T cells, CD3(+)CD56(+) NKT-like cells, and CD3(-)CD56(+) NK cells to CD45(+) leukocytes were significantly reduced in patients with PM compared to those without PM. In patients with PM, the rates of CD8 (+) T cells and NKT-like cells correlated inversely with the tumor leukocyte ratio (TLR), the relative frequency of CD326(+) tumor cells to CD45(+) leukocytes. In contrast, the proportion of CD19(+) B cells was significantly increased in patients with PM, and their proportion correlated positively with the TLR and peritoneal carcinomatosis index (PCI) score. In patients with PM, CD14(+) macrophages tended to be increased with enhanced expression of CD14, CD16 and a M2-macrophage marker, CD163. In particular, macrophages in patients with high TLR contained many granules with high side scatter and CD14 expression in their flow profile compared to those without PM. CONCLUSION: PM are accompanied by a drastic change in phenotypes of lymphocyte and macrophage in the peritoneal cavity, which might be involved in the development and progression of intraperitoneal tumor growth. Frontiers Media S.A. 2022-09-02 /pmc/articles/PMC9478385/ /pubmed/36119051 http://dx.doi.org/10.3389/fimmu.2022.969468 Text en Copyright © 2022 Takahashi, Kurashina, Yamaguchi, Kanamaru, Ohzawa, Miyato, Saito, Hosoya, Lefor, Sata and Kitayama https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Takahashi, Kazuya
Kurashina, Kentaro
Yamaguchi, Hironori
Kanamaru, Rihito
Ohzawa, Hideyuki
Miyato, Hideyo
Saito, Shin
Hosoya, Yoshinori
Lefor, Alan Kawarai
Sata, Naohiro
Kitayama, Joji
Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer
title Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer
title_full Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer
title_fullStr Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer
title_full_unstemmed Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer
title_short Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer
title_sort altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478385/
https://www.ncbi.nlm.nih.gov/pubmed/36119051
http://dx.doi.org/10.3389/fimmu.2022.969468
work_keys_str_mv AT takahashikazuya alteredintraperitonealimmunemicroenvironmentinpatientswithperitonealmetastasesfromgastriccancer
AT kurashinakentaro alteredintraperitonealimmunemicroenvironmentinpatientswithperitonealmetastasesfromgastriccancer
AT yamaguchihironori alteredintraperitonealimmunemicroenvironmentinpatientswithperitonealmetastasesfromgastriccancer
AT kanamarurihito alteredintraperitonealimmunemicroenvironmentinpatientswithperitonealmetastasesfromgastriccancer
AT ohzawahideyuki alteredintraperitonealimmunemicroenvironmentinpatientswithperitonealmetastasesfromgastriccancer
AT miyatohideyo alteredintraperitonealimmunemicroenvironmentinpatientswithperitonealmetastasesfromgastriccancer
AT saitoshin alteredintraperitonealimmunemicroenvironmentinpatientswithperitonealmetastasesfromgastriccancer
AT hosoyayoshinori alteredintraperitonealimmunemicroenvironmentinpatientswithperitonealmetastasesfromgastriccancer
AT leforalankawarai alteredintraperitonealimmunemicroenvironmentinpatientswithperitonealmetastasesfromgastriccancer
AT satanaohiro alteredintraperitonealimmunemicroenvironmentinpatientswithperitonealmetastasesfromgastriccancer
AT kitayamajoji alteredintraperitonealimmunemicroenvironmentinpatientswithperitonealmetastasesfromgastriccancer